I played around with some known parameters before the last...

I played around with some known parameters before the last quarterly and was extremely disappointed with the adoption.
I would have thought clinics onboarded around $400k worth of patients for devices and data services.

Now I expect the uptake to be slow and would like to see some sort of cost reduction initiatives. Would think after devices are developed and manufacturing is progressing R&D spend could be reduced - apart from usual (software) integration efforts.

Still waiting for updates on the other potential agreements.
Of all those papers demonstrating the value of the solution I would really like to understand why so many clinics after having multiple meetings with ADR do not go into "decision mode".
Maybe it's a simple numbers game and the revenue they expect from the partnership doesn't justify the cost to implement the platform for their specific footprint of patients.